Mortality, utility and costs inputs
| Input type | Value | References | |
| Annual background mortality | Men | Women | 36 |
| Age 18–19 | 0.009% | 0.007% | |
| Age 20–24 | 0.012% | 0.011% | |
| Age 25–29 | 0.013% | 0.011% | |
| Age 30–34 | 0.014% | 0.013% | |
| Age 35–39 | 0.020% | 0.017% | |
| Age 40–44 | 0.035% | 0.028% | |
| Age 45–49 | 0.059% | 0.043% | |
| Age 50–54 | 0.099% | 0.070% | |
| Age 55–59 | 0.176% | 0.119% | |
| Age 60–64 | 0.307% | 0.211% | |
| Age 65–69 | 0.527% | 0.373% | |
| Age 70–74 | 0.894% | 0.653% | |
| Age 75–79 | 1.484% | 1.128% | |
| Age 80–84 | 2.600% | 2.063% | |
| Age 85–89 | 4.223% | 3.512% | |
| 28 day post-AMI mortality | Men | Women | 19 |
| 35–44 | 12% | 18% | |
| 45–54 | 21% | 23% | |
| 55–64 | 29% | 27% | |
| 65–74 | 33% | 43% | |
| 75–84 | 48% | 51% | |
| 28 day poststroke mortality | Men | Women | 19 |
| 35–44 | 25% | 18% | |
| 45–54 | 18% | 14% | |
| 55–64 | 12% | 15% | |
| 65–74 | 20% | 20% | |
| 75–84 | 45% | 45% | |
| Age-specific utility | Men | Women | 41 |
| 15–19 | 0.898 | 0.896 | |
| 20–24 | 0.888 | 0.882 | |
| 25–29 | 0.878 | 0.867 | |
| 30–34 | 0.86 | 0.848 | |
| 35–39 | 0.848 | 0.832 | |
| 40–44 | 0.834 | 0.815 | |
| 45–49 | 0.814 | 0.792 | |
| 50–54 | 0.793 | 0.772 | |
| 55–59 | 0.774 | 0.752 | |
| 60–64 | 0.751 | 0.728 | |
| 65–69 | 0.725 | 0.702 | |
| 70–74 | 0.701 | 0.685 | |
| 75–79 | 0.684 | 0.669 | |
| 80–84 | 0.662 | 0.655 | |
| 85–89 | 0.661 | 0.643 | |
| One-month acute disutility | Men and women | 42 | |
| AMI | 0.439 | ||
| Stroke | 0.920 | ||
| Postevent long-term disutility | Men and women | 42 43 | |
| AMI | 0.107 | ||
| Stroke | 0.266 | ||
| Unstable angina | 0.124 | ||
| Costs (in 2018 CN￥) | Men and women | ||
| AMI and unstable angina | Stroke | ||
| Hospitalisation costs (2015 US$) | US$2630 | US$1977 | 64 |
| First year long-term costs (2015 US$) | US$602 | US$369 | 19 |
| Office visit costs in subsequent years (2015 US$) | US$66 | US$77 | 65 |
AMI, acute myocardial infarction.